Elizabethtown Hematology Oncology, an oncology practice, and its owners agreed to pay $3.7 million to settle allegations that it diluted patients’ chemotherapy treatments and delivered them over an extended period of time in order to increase its payments from government health care programs. Additionally, the company allegedly billed for unnecessary examinations while patients were receiving chemotherapy. The U.S. Attorney for the Western District of Kentucky said that the company’s actions showed “an extraordinary lack of regard for patient welfare and the integrity of our health care system.” As part of the settlement, the company entered into a Corporate Integrity Agreement with the HHS OIG.

Read the entire press release, “Owners Of Elizabethtown Hematology Oncology, PLC Agree To Pay Over $3.7 Million To Settle False Billings To Government Health Care Programs”